| Literature DB >> 23805208 |
Hyun-Jeong Lee1, Mi Jang, Hyeongmin Kim, Woori Kwak, Woncheoul Park, Jae Yeon Hwang, Chang-Kyu Lee, Gul Won Jang, Mi Na Park, Hyeong-Cheol Kim, Jin Young Jeong, Kang Seok Seo, Heebal Kim, Seoae Cho, Bo-Young Lee.
Abstract
Adipocytes mainly function as energy storage and endocrine cells. Adipose tissues showed the biological and genetic difference based on their depots. The difference of adipocytes between depots might be influenced by the inherent genetic programing for adipogenesis. We used RNA-seq technique to investigate the transcriptomes in 3 adipose tissues of omental (O), subcutaneous (S) and intramuscular (I) fats in cattle. Sequence reads were obtained from Illumina HiSeq2000 and mapped to the bovine genome using Tophat2. Differentially expressed genes (DEG) between adipose tissues were detected by EdgeR. We identified 5797, 2156, and 5455 DEGs in the comparison between OI, OS, and IS respectively and also found 5657 DEGs in the comparison between the intramuscular and the combined omental and subcutaneous fats (C) (FDR<0.01). Depot specifically up- and down- regulated DEGs were 853 in S, 48 in I, and 979 in O. The numbers of DEGs and functional annotation studies suggested that I had the different genetic profile compared to other two adipose tissues. In I, DEGs involved in the developmental process (eg. EGR2, FAS, and KLF7) were up-regulated and those in the immune system process were down-regulated. Many DEGs from the adipose tissues were enriched in the various GO terms of developmental process and KEGG pathway analysis showed that the ECM-receptor interaction was one of commonly enriched pathways in all of the 3 adipose tissues and also functioned as a sub-pathway of other enriched pathways. However, genes involved in the ECM-receptor interaction were differentially regulated depending on the depots. Collagens, main ECM constituents, were significantly up-regulated in S and integrins, transmembrane receptors, were up-regulated in I. Different laminins were up-regulated in the different depots. This comparative transcriptome analysis of three adipose tissues suggested that the interactions between ECM components and transmembrane receptors of fat cells depend on the depot specific adipogenesis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23805208 PMCID: PMC3689780 DOI: 10.1371/journal.pone.0066267
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Cox-Reid common dispersion between adipose depots.
(a) Omental vs. Intramuscular, (b) intramuscular vs. subcutaneous, and (c) omental vs. subcutaneous.
Summary of DEG identified from the comparison among three different adipose tissues (FDR<0.01).
| Paired comparison | ||||
| OS | OI | IS | IC | |
| No. of DEG | 2156 | 5797 | 5454 | 5657 |
| up-regulated in (tissue) | 836 (S) | 3080 (I) | 2399 (S) | 2992 (I) |
| 1320 (O) | 2717 (O) | 3055 (I) | 2665 (C) | |
|
| ||||
|
|
|
| ||
|
|
|
| ||
| No. of DEG | 979 | 4276 | 853 | |
| up-regulated | 621 | 2507 | 302 | |
| down-regulated | 358 | 1769 | 551 | |
Figure 2The correlation of fold changes in gene expression between the RNA seq and qRT-PCR.
Identified DEGs involving in adipogenesis, signaling pathway, and lipid metabolism.
| Gene | Full Name | Tissues expressed | Reference |
|
| adiponectin, C1Q, and collagen domain containing | I(−) | Wang et al 2009 |
|
| bone morphogenetic proteins 2 | O(−) | Rosen and MacDougald 2006 |
|
| bone morphogenetic proteins 4 | S(−) | Rosen and MacDougald 2006 |
|
| cyclin-dependent kinase 6 | I(+) | Sarruf et al 2005 |
|
| CCAAT/enhancer binding protein (C/EBP), gamma | I(+) | Rosen and MacDougald 2006 |
|
| DNA-damage-inducible transcipt 3 (CHOP) | I(+) | Darlington at al 1998 |
|
| diacylglycerol acyltransferase | I(−) | Jeong et al 2012 |
|
| early B-cell factor 1 | O(−) | Akerblad et al 2002 |
|
| early growth response 2 | I(+), S(−) | Chen et al 2005 |
|
| fatty acid binding protein4 | I(−) | Michal et al 2006 |
|
| Fas (TNF receptor superfamily, member 6) | I(+) | Wang et al 2009 |
|
| fatty acid synthase | I(−), S(+) | Jeong et al 2012 |
|
| fibroblast growth factor 1 | O(+) | Hutley et al 2004 |
|
| fibroblast growth factor 2 | S(−) | Kawaguchi et al 1997 |
|
| forkhead box C2 | I(+) | Rosen and MacDougald 2006 |
|
| GATA binding protein 2 | I(+) | Tong et al 2000 |
|
| Kruppel-like factor 5 | S(−), I(+) | Oishi et al 2005 |
|
| Kruppel-like factor 6 | I(+), O(−) | Li et al 2005 |
|
| Kruppel-like factor 7 | I(+) | Kanazawa et al 2005 |
|
| lipoprotein lipase | O(+), I(−) | Jeong et al 2012 |
|
| peroxisome profiliferator-activated receptor, gamma | I(−) | Rosen and MacDougald 2006 |
|
| peroxisome proliferator activated receptor gamma, coactivator 1 alpha | O(−) | Scime et al 2005 |
|
| thyroid hormone responsive | O(+), I(−) | Wang et al 2009 |
|
| uncoupling protein 1 | O(+) | Rosen and MacDougald 2006 |
|
| ubiquinol-cytochrome c reductase core protein 1 | I(−) | Kunej et al 2007 |
|
| wingless-type MMTV integration site family, member 10B | O(−) | Longo et al 2004 |
|
| wingless-type MMTV integration site 5B | S(−) | Kanazawa et al 2005 |
|
| wingless-type MMTV integration site 6 | I(+) | Tseng et al 2005 |
(+) : up-regulated.
(−) : down-regulated.
Figure 3Biological process GO terms analysis of depot specifically regulated DEGs (a) and DEGs identified from the comparison between I and C (b).
Figure 4Representative KEGG pathways of DEGs resulted from the pairwise comparison among different adipose depots.
Y-axis shows the number of gene counts.
KEGG pathways of DEGs involved in developmental process.
| Depot | KEGG ID | Terms | P-value |
| Omental | hsa04360 | Axon guidance | 3.25E-06 |
| hsa05200 | Pathways in cancer | 3.81E-04 | |
| hsa05217 | Basal cell carcinoma | 8.91E-04 | |
| hsa05340 | Primary immunodeficiency | 2.95E-03 | |
| hsa04514 | Cell adhesion molecules (CAMs) | 4.37E-03 | |
| hsa04512 | ECM-receptor interaction | 9.97E-03 | |
| subcutaneous | hsa04510 | Focal adhesion | 1.97E-05 |
| hsa04512 | ECM-receptor interaction | 2.39E-05 | |
| hsa05200 | Pathways in cancer | 3.60E-04 | |
| hsa04360 | Axon guidance | 6.61E-04 | |
| intramuscular | hsa05410 | Hypertrophic cardiomyopathy (HCM) | 1.24E-13 |
| hsa05414 | Dilated cardiomyopathy | 7.07E-12 | |
| hsa05200 | Pathways in cancer | 1.19E-11 | |
| hsa04510 | Focal adhesion | 5.76E-10 | |
| hsa04512 | ECM-receptor interaction | 5.21E-07 | |
| hsa04350 | TGF-beta signaling pathway | 8.81E-07 | |
| hsa04360 | Axon guidance | 1.64E-05 | |
| hsa05219 | Bladder cancer | 2.79E-05 | |
| hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 7.71E-05 | |
| hsa04010 | MAPK signaling pathway | 2.84E-04 | |
| hsa04810 | Regulation of actin cytoskeleton | 3.64E-04 | |
| hsa04630 | Jak-STAT signaling pathway | 6.07E-04 | |
| hsa04060 | Cytokine-cytokine receptor interaction | 1.14E-03 | |
| hsa04270 | Vascular smooth muscle contraction | 1.19E-03 | |
| hsa04310 | Wnt signaling pathway | 1.22E-03 | |
| hsa04115 | p53 signaling pathway | 1.76E-03 | |
| hsa05222 | Small cell lung cancer | 2.73E-03 | |
| hsa04340 | Hedgehog signaling pathway | 5.99E-03 | |
| hsa04020 | Calcium signaling pathway | 6.18E-03 | |
| hsa05210 | Colorectal cancer | 8.31E-03 |
Figure 5Visualization of molecular network in the KEGG pathway of ECM-receptor interaction using cytoscape.
Grey circles represent genes involved in the pathway and the color of the circle represent genes highly expressed in each depot (red:intramuscular, blue: omental, green: subcutaneous).